The Glucocorticoid-Induced Leucine Zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 246-255

  Lekva, Tove ^a   Bollerslev, Jens ^a   Kristo, Cybé Le ^a   Olstad, Ole Kristoffer ^b   Ueland, Thor ^a   Jemtland, Rune ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MESSENGER RNA; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BONE BIOPSY; BONE MATURATION; BONE REMODELING; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; GILZ GENE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 75149137769     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0595     Document Type: Article

References (25)

1. Canalis E, Mazziotti G, Giustina A, Bilezikian JP 2007 Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328
2. Shaker JL, Lukert BP 2005 Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 34:341-356, viii-ix
3. Woolf AD 2007 An update on glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 19:370-375
4. Vestergaard P, Lindholm J, Jørgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Kristensen LØ, Feldt-Rasmussen U, Mosekilde L 2002 Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 146:51-56
5. Francucci CM, Pantanetti P, Garrapa GG, Massi F, Arnaldi G, Mantero F 2002 Bone metabolism and mass inwomenwith Cushing's syndrome and adrenal incidentaloma. Clin Endocrinol (Oxf) 57:587-593
6. Godang K, Ueland T, Bollerslev J 1999 Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome. Eur J Endocrinol 141: 126-131
7. Lukert BP, Higgins JC, Stoskopf MM 1986 Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 62:1056-1058
8. Ishida Y, Heersche JN 1998 Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res 13:1822-1826
9. Canalis E 2005 Mechanisms of glucocorticoid action in bone. Curr Osteoporos Rep 3:98-102
10. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV 1994 Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286
11. Eijken M, Koedam M, van Driel M, Buurman CJ, Pols HA, van Leeuwen JP 2006 The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol 248:87-93
12. Khosla S 2001 Minireview: the OPG/RANKL/RANK system. Endocrinology 142:5050-5055
13. Humphrey EL, Williams JH, Davie MW, Marshall MJ 2006 Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 38:652-661
14. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389
15. Kristo C, Godang K, Ueland T, Lien E, Aukrust P, Froland SS, Bollerslev J 2002 Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome. Eur J Endocrinol 146:389-395
16. Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J 2006 Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study. Eur J Endocrinol 154:109-118
17. Shi X, Hamrick M, Isales CM 2007 Energy balance, myostatin, and GILZ: factors regulating adipocyte differentiation in belly and bone. PPAR Res 2007:92501
18. Bollerslev J, Steiniche T, Melsen F, Mosekilde L 1989 Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types. Bone 10:19-24
19. Reppe S, Stilgren L, Olstad OK, Brixen K, Nissen-Meyer LS, Gautvik KM, Abrahamsen B 2006 Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism. Bone 39:189-198
20. Reppe S, Stilgren L, Abrahamsen B, Olstad OK, Cero F, Brixen K, Nissen-Meyer LS, Gautvik KM 2007 Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab 292: E1465-E1473
21. Harris SA, Enger RJ, Riggs BL, Spelsberg TC 1995 Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178-186
22. Hicok KC, Thomas T, Gori F, Rickard DJ, Spelsberg TC, Riggs BL 1998 Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res 13:205-217
23. Nissen-Meyer LS, Jemtland R, Gautvik VT, Pedersen ME, Paro R, Fortunati D, Pierroz DD, Stadelmann VA, Reppe S, Reinholt FP, Del Fattore A, Rucci N, Teti A, Ferrari S, Gautvik KM 2007 Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. J Cell Sci 120:2785-2795
24. Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, Sandberg WJ, Paulsson-Berne G, Pedersen TM, Folkersen L, Gullestad L, Oie E, Hansson GK, Aukrust P 2009 Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis. Arterioscler Thromb Vasc Biol 29:1228-1234
25. Zhang W, Yang N, Shi XM 2008 Regulation of MSC osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J Biol Chem 283:4723-4729